Philogen S.p.A. (PHIL.MI)

EUR 21.5

(0.94%)

Operating Income Summary of Philogen S.p.A.

Philogen S.p.A.'s latest annual operating income in 2023 was -8.84 Million EUR , down -4612.92% from previous year.
Philogen S.p.A.'s latest quarterly operating income in 2023 FY was -10.83 Million EUR , down -4612.92% from previous quarter.
Philogen S.p.A. reported an annual operating income of 240 Thousand EUR in 2022, up 101.43% from previous year.
Philogen S.p.A. reported an annual operating income of -16.77 Million EUR in 2021, down -38.3% from previous year.
Philogen S.p.A. reported a quarterly operating income of -8 Million EUR for 2023 Q3, down -338.25% from previous quarter.
Philogen S.p.A. reported a quarterly operating income of 3.35 Million EUR for 2023 Q1, up 186.21% from previous quarter.

Annual Operating Income Chart of Philogen S.p.A. (2023 - 2017)

Historical Annual Operating Income of Philogen S.p.A. (2023 - 2017)

Year	Operating Income	Operating Income Growth
2023	-8.84 Million EUR	-4612.92%
2022	240 Thousand EUR	101.43%
2021	-16.77 Million EUR	-38.3%
2020	-12.12 Million EUR	-177.55%
2019	-4.37 Million EUR	-961.93%
2018	507 Thousand EUR	130.75%
2017	-1.64 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2023 Q2	3.35 Million EUR	0.0%
2023 Q3	-8 Million EUR	-338.25%
2023 Q1	3.35 Million EUR	186.21%
2023 FY	-10.83 Million EUR	-4612.92%
2023 Q4	-8 Million EUR	0.0%
2022 Q4	-3.89 Million EUR	0.0%
2022 FY	240 Thousand EUR	101.43%
2022 Q3	-3.89 Million EUR	-168.29%
2022 Q2	5.7 Million EUR	49.01%
2022 Q1	3.82 Million EUR	138.36%
2021 Q1	-4.43 Million EUR	-116.12%
2021 FY	-16.77 Million EUR	-38.3%
2021 Q4	-9.97 Million EUR	-152.06%
2021 Q3	-3.95 Million EUR	50.91%
2021 Q2	-8.06 Million EUR	-82.01%
2020 Q1	-3.17 Million EUR	-1572.11%
2020 FY	-12.12 Million EUR	-177.55%
2020 Q4	-2.04 Million EUR	0.0%
2020 Q2	-3.17 Million EUR	0.0%
2019 Q4	-190 Thousand EUR	0.0%
2019 FY	-4.37 Million EUR	-961.93%
2018 FY	507 Thousand EUR	130.75%
2017 FY	-1.64 Million EUR	0.0%

Peer Operating Income Comparison of Philogen S.p.A.

Name	Operating Income	Operating Income Difference
ARTERRA BIOSCIENCE	-1.53 Million EUR	-476.366%
Ulisse Biomed S.p.A.	-3.45 Million EUR	-155.559%